| Product Code: ETC100339 | Publication Date: Jun 2021 | Updated Date: Feb 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
Georgia human insulin market is witnessing steady growth due to the increasing prevalence of diabetes and the rising demand for effective diabetes management solutions. Human insulin, derived from recombinant DNA technology, is the primary treatment for diabetes mellitus. Factors such as the aging population, sedentary lifestyles, and unhealthy dietary habits are driving market growth.
The human insulin market in Georgia is experiencing significant growth owing to the increasing prevalence of diabetes and the rising geriatric population in the country. Human insulin is widely used for the management of diabetes mellitus, and the growing diabetic population is driving its demand in Georgia. Additionally, the availability of various types of human insulin formulations, such as rapid-acting, short-acting, intermediate-acting, and long-acting insulin, is further contributing to market growth. Moreover, the introduction of advanced insulin delivery devices and the development of biosimilar insulin products are expected to drive market expansion in the coming years.
Challenges in the human insulin market in Georgia include the rising prevalence of diabetes, which increases demand for insulin while putting pressure on pricing and accessibility. Moreover, competition from biosimilar and generic insulin products poses challenges for established insulin manufacturers.
In the human insulin market, the government of Georgia has implemented policies to ensure access to affordable insulin for all citizens. These policies include price controls on insulin products, subsidies for low-income individuals with diabetes, and efforts to promote generic competition to reduce costs.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Georgia Human Insulin Market Overview |
3.1 Georgia Country Macro Economic Indicators |
3.2 Georgia Human Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Georgia Human Insulin Market - Industry Life Cycle |
3.4 Georgia Human Insulin Market - Porter's Five Forces |
3.5 Georgia Human Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Georgia Human Insulin Market Revenues & Volume Share, By Diabetes Type, 2021 & 2031F |
3.7 Georgia Human Insulin Market Revenues & Volume Share, By Delivery Devices, 2021 & 2031F |
3.8 Georgia Human Insulin Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Georgia Human Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Georgia Human Insulin Market Trends |
6 Georgia Human Insulin Market, By Types |
6.1 Georgia Human Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Georgia Human Insulin Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Georgia Human Insulin Market Revenues & Volume, By Analogue Insulin, 2021-2031F |
6.1.4 Georgia Human Insulin Market Revenues & Volume, By Traditional Human Insulin, 2021-2031F |
6.2 Georgia Human Insulin Market, By Diabetes Type |
6.2.1 Overview and Analysis |
6.2.2 Georgia Human Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021-2031F |
6.2.3 Georgia Human Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021-2031F |
6.2.4 Georgia Human Insulin Market Revenues & Volume, By Gestational Diabetes, 2021-2031F |
6.2.5 Georgia Human Insulin Market Revenues & Volume, By Prediabetes, 2021-2031F |
6.3 Georgia Human Insulin Market, By Delivery Devices |
6.3.1 Overview and Analysis |
6.3.2 Georgia Human Insulin Market Revenues & Volume, By Syringes, 2021-2031F |
6.3.3 Georgia Human Insulin Market Revenues & Volume, By Pens, 2021-2031F |
6.3.4 Georgia Human Insulin Market Revenues & Volume, By Pumps, 2021-2031F |
6.3.5 Georgia Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
6.4 Georgia Human Insulin Market, By End-users |
6.4.1 Overview and Analysis |
6.4.2 Georgia Human Insulin Market Revenues & Volume, By Home Healthcare, 2021-2031F |
6.4.3 Georgia Human Insulin Market Revenues & Volume, By Hospitals, 2021-2031F |
6.4.4 Georgia Human Insulin Market Revenues & Volume, By Over The Counter (OTC), 2021-2031F |
6.4.5 Georgia Human Insulin Market Revenues & Volume, By Clinics, 2021-2031F |
6.4.6 Georgia Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
7 Georgia Human Insulin Market Import-Export Trade Statistics |
7.1 Georgia Human Insulin Market Export to Major Countries |
7.2 Georgia Human Insulin Market Imports from Major Countries |
8 Georgia Human Insulin Market Key Performance Indicators |
9 Georgia Human Insulin Market - Opportunity Assessment |
9.1 Georgia Human Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Georgia Human Insulin Market Opportunity Assessment, By Diabetes Type, 2021 & 2031F |
9.3 Georgia Human Insulin Market Opportunity Assessment, By Delivery Devices, 2021 & 2031F |
9.4 Georgia Human Insulin Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Georgia Human Insulin Market - Competitive Landscape |
10.1 Georgia Human Insulin Market Revenue Share, By Companies, 2024 |
10.2 Georgia Human Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |